Glaukos (GKOS) Cash from Operations Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 25.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.88% |
| Dec 31, 2025 | 53.99% |
| Sep 30, 2025 | 27.53% |
| Jun 30, 2025 | 37.01% |
| Mar 31, 2025 | -57.34% |
| Dec 31, 2024 | 28.24% |
| Sep 30, 2024 | -36.42% |
| Jun 30, 2024 | -64.92% |
| Mar 31, 2024 | -116.21% |
| Dec 31, 2023 | -44.32% |
| Sep 30, 2023 | 5.14% |
| Jun 30, 2023 | 9.26% |
| Mar 31, 2023 | -32.92% |
| Dec 31, 2022 | 0.44% |
| Sep 30, 2022 | -107.03% |
| Jun 30, 2022 | -56.71% |
| Mar 31, 2022 | 260.86% |
| Dec 31, 2021 | -31.45% |
| Sep 30, 2021 | 59.77% |
| Jun 30, 2021 | 24.54% |
| Mar 31, 2021 | 38.34% |
| Dec 31, 2020 | -5.24% |
| Sep 30, 2020 | -49.91% |
| Jun 30, 2020 | -65.50% |
| Mar 31, 2020 | -96.88% |
| Dec 31, 2019 | -48.56% |
| Sep 30, 2019 | -40.28% |
| Jun 30, 2019 | 3.02% |
| Mar 31, 2019 | 30.49% |
| Dec 31, 2018 | 217.64% |
| Sep 30, 2018 | 114.22% |
| Jun 30, 2018 | 87.25% |
| Mar 31, 2018 | -84.16% |
| Dec 31, 2017 | 118.02% |
| Sep 30, 2017 | 157.96% |
| Jun 30, 2017 | 186.24% |